title: Clinical utility of counting intraepithelial lymphocytes in celiac disease intestinal mucosa.
abstract: OBJECTIVE
  Our aims were to establish the clinical utility of assessing the intraepithelial lymphocyte (IEL) density in intestinal biopsies from a large series of individuals and to determine the best threshold discriminating celiac disease (CD) patients and controls in two populations with different pre-test prevalence.
  
  
  METHODS
  We prospectively performed intestinal biopsy and CD-related serology in 349 subjects undergoing upper GI endoscopy. While 116 had symptoms suggestive of a small bowel disorder (high prevalence), 233 individuals were randomly selected from patients referred to endoscopy because upper GIsymptoms (low prevalence). Diagnosis of CD was based on the concordance of classical histological features and a positive CD serology.
  
  
  RESULTS
  While 58 patients had a newly diagnosed CD (52 in the high and 6 in the low prevalence groups), 291 subjects did not meet diagnostic criteria of the disorder. Patients had a highly significant greater IEL density than controls (p < 0.00001). Based on the ROC curve, a count of 22.8 IEL/100 epithelial cells had the highest performance for diagnosing CD in the overall population and for subjects in the high pre-test probability subgroup and 22.5% was ,he best cut-off for those diagnosed in the low risk population (area under the curves: 0.979, 0.979 and 0.993, respectively). An abnormal CD serology confirmed the diagnosis of CD in all the four patients with counts below 22.8%.
  
  
  CONCLUSIONS
  Our study confirms that an IEL density of 22.8% is an adequate threshold to discriminate CD patients and controls in individuals irrespective of the prevalence of the disorder.
authors.affiliation: Small Bowel Section, Department of Medicine, Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo, Av. Caseros 2061 (1264) Ciudad Autónoma de Buenos Aires, Argentina.
authors.forename: Ana
authors.initials: A
authors.lastname: Cabanne
authors.forename: Horacio
authors.initials: H
authors.lastname: Vázquez
authors.forename: Julio
authors.initials: J
authors.lastname: Argonz
authors.forename: María L
authors.initials: ML
authors.lastname: Moreno
authors.forename: Fabio
authors.initials: F
authors.lastname: Nachman
authors.forename: Sonia
authors.initials: S
authors.lastname: Niveloni
authors.forename: Roberto
authors.initials: R
authors.lastname: Mazure
authors.forename: Zulema
authors.initials: Z
authors.lastname: Kogan
authors.forename: Juan C
authors.initials: JC
authors.lastname: Gómez
authors.forename: Eduardo
authors.initials: E
authors.lastname: Mauriño
authors.forename: Julio C
authors.initials: JC
authors.lastname: Bai
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D016022:Case-Control Studies; D002446:Celiac Disease / Q000175:diagnosis* / Q000276:immunology; D005260:Female; D006801:Humans; D007413:Intestinal Mucosa / Q000166:cytology*; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012372:ROC Curve; D012680:Sensitivity and Specificity